doi: 10.1016/j.diabet.2018.12.001
Patients on biologic immunosuppressants (infliximab, vedolizumab, ustekinumab) should avoid GLP-1 therapy unless their gastroenterologist explicitly approves, since combining immune-modulating drugs increases infection and flare risk
Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor
Avoid carbonated beverages, high-fat foods, and rapid eating, all of which can worsen digestive discomfort when you're adjusting to semaglutide
normal functioning of the nervous system
If this happens occasionally, continue with your normal routine and take your next dose correctly the following daydo not take an additional dose to compensate